Predictors of progression and delayed intervention in small renal mass patients undergoing active surveillance without health-related selection bias

The Journal of Urology(2023)

引用 0|浏览2
暂无评分
摘要
You have accessJournal of UrologyCME1 Apr 2023PD08-12 PREDICTORS OF PROGRESSION AND DELAYED INTERVENTION IN SMALL RENAL MASS PATIENTS UNDERGOING ACTIVE SURVEILLANCE WITHOUT HEALTH-RELATED SELECTION BIAS Muammer Altok, Arun Menon, Ahmed Aly, Kristopher Attwood, Tashionna White, Gaybrielle James, Bo Xu, Michael Petroziello, Charles Roche, and Eric Kauffman Muammer AltokMuammer Altok More articles by this author , Arun MenonArun Menon More articles by this author , Ahmed AlyAhmed Aly More articles by this author , Kristopher AttwoodKristopher Attwood More articles by this author , Tashionna WhiteTashionna White More articles by this author , Gaybrielle JamesGaybrielle James More articles by this author , Bo XuBo Xu More articles by this author , Michael PetrozielloMichael Petroziello More articles by this author , Charles RocheCharles Roche More articles by this author , and Eric KauffmanEric Kauffman More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003239.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Active surveillance (AS) allows many patients with small renal masses (SRM) to avoid treatment, however study of progression and delayed intervention (DI) outcomes has been limited by high proportions of observation patients who are unfit for treatment. We recently described our initial clinical experience prospectively using pre-defined progression criteria for intervention (PCI) in a unique AS cohort of SRM patients lacking health-related selection. Our current objective was to identify predictors of PCI development and DI in this cohort. METHODS: From January 2013-March 2019, all patients with non-hereditary SRM seen by a single urologic oncologist at a National Comprehensive Cancer Network institute were recommended AS if predefined PCI were absent. PCI were defined prospectively as any SRM-related symptoms, unfavorable biopsy histology, cT3a stage, or any of the following without benign neoplastic biopsy histology: longest tumor diameter (LTD) >4 cm; growth rate >5 mm/year for LTD ≤3 cm or >3 mm/year for LTD >3 cm. DI was recommended during AS upon new PCI development. 5-year PCI-free and DI-free survival were assessed using Kaplan-Meier methods. Clinical variables at presentation or during AS (sex, age, race, body mass index, comorbidities, initial tumor number/size, biopsy histology) were tested for association with time to PCI development or DI. RESULTS: Of 208 consecutive SRM patients, 201 were PCI-free at presentation and underwent AS. With median follow up of 46 months, there were no metastases, and new PCI was diagnosed in 30% of AS patients, of which 69% underwent DI. Only 1 (1%) patient crossed over to DI without tumor PCI. 5-year PCI- and DI-free rates were 60% and 71%, respectively. On univariable analyses, shorter time to PCI was significantly associated with non-Caucasian race, lower Charlson score, initial LTD, and clear cell biopsy histology, while the latter 3 variables also significantly predicted shorter time to DI. On multivariable analyses including all variables, only clear cell biopsy histology independently predicted PCI and DI. On multivariable analyses excluding biopsy histology, only initial LTD independently predicted PCI and DI. CONCLUSIONS: Among SRM patients undergoing AS without health-related selection, LTD and clear cell biopsy histology are primary drivers of PCI development and DI. Non-Caucasian race and fewer comorbidities increase progression risk but not independently of LTD and histology. These findings may be useful for counseling AS patient candidates. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e237 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Muammer Altok More articles by this author Arun Menon More articles by this author Ahmed Aly More articles by this author Kristopher Attwood More articles by this author Tashionna White More articles by this author Gaybrielle James More articles by this author Bo Xu More articles by this author Michael Petroziello More articles by this author Charles Roche More articles by this author Eric Kauffman More articles by this author Expand All Advertisement PDF downloadLoading ...
更多
查看译文
关键词
small renal mass patients,delayed intervention,health-related
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要